Medgenics Reports First Quarter Financial Results
[GlobeNewswire] – WAYNE, Pa. and MISGAV, Israel — Medgenics, Inc. (NYSE MKT:MDGN), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using ex-vivo … moreView todays social media effects on MDGNView the latest stocks trending across Twitter. Click to view dashboardSee who Medgenics is hiring next, click here to view […]